DEUTSCHE BANK AG\
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in REGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$323,248,743
-$159,951,034 QoQ
Shares Held
518,409
-17.1% QoQ
Ownership
0.504%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#31
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. REGN ranks #2 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $323,248,743 | 518,409 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $483,199,777 | 625,388 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $589,651,555 | 763,926 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $391,722,818 | 696,681 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $373,189,425 | 710,837 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $344,445,232 | 543,092 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $384,137,478 | 539,269 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $465,636,238 | 442,940 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $421,643,799 | 401,172 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $300,370,023 | 312,076 | Shares | Sole | 2025-06-02 | |
| 2023-12-31 | $285,791,166 | 325,395 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $223,541,441 | 271,631 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $215,404,632 | 299,781 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $248,762,230 | 302,752 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $233,790,171 | 324,038 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $224,057,716 | 325,254 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $214,476,143 | 362,824 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $287,752,523 | 412,005 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $262,043,530 | 414,941 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $271,700,393 | 448,958 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $280,225,654 | 501,711 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $219,660,915 | 464,262 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $207,626,658 | 429,771 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $210,957,004 | 376,857 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $225,462,565 | 361,521 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $191,076,660 | 391,318 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||